Becton Dickinson (BDX) Gross Margin (2009 - 2026)
Becton Dickinson's (BDX) quarterly Gross Margin came in at 46.46% in Q2 2026, down 83.0% year-over-year from 273.28% in Q2 2025, and up 1.67% quarter-over-quarter from 45.69% in Q1 2026.
Analysis
Becton Dickinson (BDX) Gross Margin (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Gross Margin for 18 consecutive years, with 46.46% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin fell 83.0% year-over-year to 46.46% in Q2 2026; TTM through Jun 2026 was 46.93%, a 242.0% increase from a year earlier, with the FY2025 full-year figure at 45.44%, up 22.0% from the prior year.
- Gross Margin was 46.46% for Q2 2026 at Becton Dickinson, up from 45.69% in the prior quarter.
- Over five years, Gross Margin peaked at 48.57% in Q3 2025 and troughed at 33.44% in Q3 2023.
- A 5-year average of 44.52% and a median of 45.68% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 1019 bps in 2023 and soared 1230 bps in 2024, its largest moves.
- Over 5 years, Gross Margin stood at 46.51% in 2022, then dropped by 7 bps to 43.07% in 2023, then grew by 0 bps to 43.25% in 2024, then advanced by 6 bps to 45.91% in 2025, then increased by 1 bps to 46.46% in 2026.
- The last three Gross Margin figures came in at 46.46% (Q2 2026), 45.69% (Q1 2026), and 45.91% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.76 Bn | 47.89 Bn | 2.32 Bn | 46.46% |
| 2 | Medline | 28.23 Bn | 25.55 Bn | 2.22 Bn | 28.82% |
| 3 | West Pharmaceutical Services | 23.61 Bn | 23.18 Bn | 329.20 Mn | 37.74% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 34.86% |
| 5 | Stevanato Group S.p.A | 5.63 Bn | 5.52 Bn | 100.91 Mn | 28.75% |
| 6 | Acme United | 233.52 Mn | 228.48 Mn | 26.69 Mn | 42.55% |
| 7 | Rockwell Medical | 29.73 Mn | 4.93 Mn | 3.24 Mn | 18.24% |
| 8 | Retractable Technologies | 20.96 Mn | -18.91 Mn | 190,852.00 | 2.65% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.68 Mn | 4.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.46% |
| Mar 31, 2026 | 45.69% |
| Dec 31, 2025 | 45.91% |
| Sep 30, 2025 | 48.57% |
| Jun 30, 2025 | 47.29% |
| Mar 31, 2025 | 41.54% |
| Dec 31, 2024 | 43.25% |
| Sep 30, 2024 | 45.74% |
| Jun 30, 2024 | 46.23% |
| Mar 31, 2024 | 45.67% |
| Dec 31, 2023 | 43.07% |
| Sep 30, 2023 | 33.44% |
| Jun 30, 2023 | 43.05% |
| Mar 31, 2023 | 46.36% |
| Dec 31, 2022 | 46.51% |
| Sep 30, 2022 | 43.63% |
| Jun 30, 2022 | 44.54% |
| Mar 31, 2022 | 44.48% |
| Dec 31, 2021 | 47.05% |
| Sep 30, 2021 | 43.04% |